Filing Details
- Accession Number:
- 0001209191-17-050892
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-31 17:16:18
- Reporting Period:
- 2017-08-30
- Accepted Time:
- 2017-08-31 16:16:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1578408 | Nick Leschly | C/O Bluebird Bio, Inc. 60 Binney Street Cambridge MA 02142 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-06-29 | 10,000 | $0.00 | 339,368 | No | 5 | G | Direct | |
| Common Stock | Disposition | 2017-08-30 | 25,667 | $115.18 | 313,701 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 17,186 | Indirect | Nick Leschly 2001 Trust |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2016.
- The range of prices for the transaction reported on this line was $115.00 to $115.75. The average weighted price was $115.1793. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
